B

Bioton SA
WSE:BIO

Watchlist Manager
Bioton SA
WSE:BIO
Watchlist
Price: 3.76 PLN 0.53% Market Closed
Market Cap: 322.8m PLN

Wall Street
Price Targets

BIO Price Targets Summary
Bioton SA

There are no price targets for BIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Bioton SA Competitors:
Price Targets
GNS
Genus PLC
15% Upside
OPK
OPKO Health Inc
190% Upside
2696
Shanghai Henlius Biotech Inc
69% Upside
OXB
Oxford BioMedica PLC
24% Upside
ORY
Oryzon Genomics SA
130% Upside
ADCT
ADC Therapeutics SA
132% Upside
PRQR
ProQR Therapeutics NV
350% Upside
XGN
Exagen Inc
157% Upside

Revenue
Forecast

Revenue Estimate
Bioton SA

For the last 13 years the compound annual growth rate for Bioton SA's revenue is -3%. The projected CAGR for the next 10 years is 5%.

-3%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bioton SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-33%
Average Miss

Net Income
Forecast

Net Income Estimate
Bioton SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIO's stock price target?
Not Available

BIO doesn't have any price targets made by Wall Street professionals.

What is Bioton SA's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Bioton SA's revenue is -3%. The projected CAGR for the next 10 years is 5%.

Back to Top